메뉴 건너뛰기




Volumn 19, Issue 2, 2007, Pages 226-227

Anti-ischemic effects of sildenafil, vardenafil and tadalafil in heart

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL;

EID: 33847365760     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901533     Document Type: Letter
Times cited : (12)

References (6)
  • 1
    • 33846059081 scopus 로고    scopus 로고
    • The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size
    • Sesti C, Florio V, Johnson EG, Kloner RA. The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size. Int J Impot Res 2007; 19: 55-61.
    • (2007) Int J Impot Res , vol.19 , pp. 55-61
    • Sesti, C.1    Florio, V.2    Johnson, E.G.3    Kloner, R.A.4
  • 2
    • 1042298055 scopus 로고    scopus 로고
    • Cardioprotection with phosphodiesterase-5 inhibition - a novel preconditioning strategy
    • Kukreja RC, Ockaili R, Salloum F, Yin C, Hawkins J, Das A et al. Cardioprotection with phosphodiesterase-5 inhibition - a novel preconditioning strategy. J Mol Cell Cardiol 2004; 36: 165-173.
    • (2004) J Mol Cell Cardiol , vol.36 , pp. 165-173
    • Kukreja, R.C.1    Ockaili, R.2    Salloum, F.3    Yin, C.4    Hawkins, J.5    Das, A.6
  • 3
    • 0036350615 scopus 로고    scopus 로고
    • Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial KATP channels in rabbits
    • Ockaili R, Salloum F, Hawkins J, Kukreja RC. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial KATP channels in rabbits. Am J Physiol Heart Circ Physiol 2002; 283: H1263-H1269.
    • (2002) Am J Physiol Heart Circ Physiol , vol.283
    • Ockaili, R.1    Salloum, F.2    Hawkins, J.3    Kukreja, R.C.4
  • 6
    • 33847367689 scopus 로고    scopus 로고
    • The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems
    • Schwarz ER, Kapur V, Rodriguez J, Rastogi S, Rosanio S. The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems. Int J Impot Res 2007; 19: 139-148.
    • (2007) Int J Impot Res , vol.19 , pp. 139-148
    • Schwarz, E.R.1    Kapur, V.2    Rodriguez, J.3    Rastogi, S.4    Rosanio, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.